PharmAust’s MPL trials show doubled life expectancy for dogs with cancer
PharmAust’s MPL trials show doubled life expectancy for dogs with cancer (External Link)
PharmAust (ASX:PAA) sees “significant progress” in dog cancer trials
PharmAust (ASX:PAA) sees “significant progress” in dog cancer trials (External Link)
Top 20 Shareholders
Top_Holders_Report (4)
PharmAust opens door to billion-dollar markets, following MPL trial successes
PharmAust opens door to billion-dollar markets, following MPL trial successes (External Link)
Broker JP Equity says PharmAust has multiple avenues to $US 1 billion+ success
Broker JP Equity says PharmAust has multiple avenues to $US 1 billion+ success (External Link)
JP Equity Research Report
JP Equity Research Note – July 2022
Appendix 4C and Quarterly Update
Appendix 4C and Quarterly Update – June 2022
PharmAust subsidiary Epichem lands pilot deal with Shell Australia to convert waste plastic to products
Learn More (External Link)
July 1, Top 20 Shareholders
220701_Top_Holders_Report (5)
Science Week Conference Presentation
Science Week Conference Presentation – June 2022